Cargando…

Clinical heterogeneity in monogenic chylomicronaemia

Chylomicronaemia accompanies hypertriglyceridaemia, usually due to a polygenic predisposition in combination with secondary risk factors. Monogenic chylomicronaemia represents a small subgroup of patients with hypertriglyceridaemia. This article describes three patients and illustrates the heterogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Heidemann, Britt E, Bemelmans, Remy H H, Marais, A David, Visseren, Frank L J, Koopal, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693862/
https://www.ncbi.nlm.nih.gov/pubmed/36423940
http://dx.doi.org/10.1136/bcr-2022-251411
_version_ 1784837651375849472
author Heidemann, Britt E
Bemelmans, Remy H H
Marais, A David
Visseren, Frank L J
Koopal, Charlotte
author_facet Heidemann, Britt E
Bemelmans, Remy H H
Marais, A David
Visseren, Frank L J
Koopal, Charlotte
author_sort Heidemann, Britt E
collection PubMed
description Chylomicronaemia accompanies hypertriglyceridaemia, usually due to a polygenic predisposition in combination with secondary risk factors. Monogenic chylomicronaemia represents a small subgroup of patients with hypertriglyceridaemia. This article describes three patients and illustrates the heterogeneity in the presentation of monogenic chylomicronaemia. The first case is a man with mild hypertriglyceridaemia who is a compound heterozygote for two variants in the LMF1 gene, without relevant medical history. The second case is a woman who is a double heterozygote of variants in the LPL and APOA5 genes. She experienced pancreatitis. The third case is a man, with recurrent pancreatitis attributed to severe hypertriglyceridaemia and homozygous for a variant in the APOC2 gene. This article highlights that in patients with hypertriglyceridaemia, the absence of pancreatitis or the presence of mild hypertriglyceridaemia does not exclude monogenic chylomicronaemia. Genetic screening should be considered in patients with unexplained or severe hypertriglyceridaemia, to determine appropriate treatment and follow-up.
format Online
Article
Text
id pubmed-9693862
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-96938622022-11-26 Clinical heterogeneity in monogenic chylomicronaemia Heidemann, Britt E Bemelmans, Remy H H Marais, A David Visseren, Frank L J Koopal, Charlotte BMJ Case Rep Case Reports: Rare disease Chylomicronaemia accompanies hypertriglyceridaemia, usually due to a polygenic predisposition in combination with secondary risk factors. Monogenic chylomicronaemia represents a small subgroup of patients with hypertriglyceridaemia. This article describes three patients and illustrates the heterogeneity in the presentation of monogenic chylomicronaemia. The first case is a man with mild hypertriglyceridaemia who is a compound heterozygote for two variants in the LMF1 gene, without relevant medical history. The second case is a woman who is a double heterozygote of variants in the LPL and APOA5 genes. She experienced pancreatitis. The third case is a man, with recurrent pancreatitis attributed to severe hypertriglyceridaemia and homozygous for a variant in the APOC2 gene. This article highlights that in patients with hypertriglyceridaemia, the absence of pancreatitis or the presence of mild hypertriglyceridaemia does not exclude monogenic chylomicronaemia. Genetic screening should be considered in patients with unexplained or severe hypertriglyceridaemia, to determine appropriate treatment and follow-up. BMJ Publishing Group 2022-11-23 /pmc/articles/PMC9693862/ /pubmed/36423940 http://dx.doi.org/10.1136/bcr-2022-251411 Text en © BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Case Reports: Rare disease
Heidemann, Britt E
Bemelmans, Remy H H
Marais, A David
Visseren, Frank L J
Koopal, Charlotte
Clinical heterogeneity in monogenic chylomicronaemia
title Clinical heterogeneity in monogenic chylomicronaemia
title_full Clinical heterogeneity in monogenic chylomicronaemia
title_fullStr Clinical heterogeneity in monogenic chylomicronaemia
title_full_unstemmed Clinical heterogeneity in monogenic chylomicronaemia
title_short Clinical heterogeneity in monogenic chylomicronaemia
title_sort clinical heterogeneity in monogenic chylomicronaemia
topic Case Reports: Rare disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693862/
https://www.ncbi.nlm.nih.gov/pubmed/36423940
http://dx.doi.org/10.1136/bcr-2022-251411
work_keys_str_mv AT heidemannbritte clinicalheterogeneityinmonogenicchylomicronaemia
AT bemelmansremyhh clinicalheterogeneityinmonogenicchylomicronaemia
AT maraisadavid clinicalheterogeneityinmonogenicchylomicronaemia
AT visserenfranklj clinicalheterogeneityinmonogenicchylomicronaemia
AT koopalcharlotte clinicalheterogeneityinmonogenicchylomicronaemia